Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
39,662,028
-
Shares change
-
-4,474,584
-
Total reported value, excl. options
-
$56,340,358
-
Value change
-
-$2,625,416
-
Put/Call ratio
-
9.03%
-
Number of buys
-
25
-
Number of sells
-
-24
-
Price
-
$1.43
Significant Holders of TRANSENTERIX INC - COM NEW (TRXC) as of Q3 2017
76 filings reported holding TRXC - TRANSENTERIX INC - COM NEW as of Q3 2017.
TRANSENTERIX INC - COM NEW (TRXC) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39,662,028 shares
.
Largest 10 shareholders include Aisling Capital LLC (10,335,819 shares), SV Health Investors, LLC (7,546,692 shares), JPMORGAN CHASE & CO (4,230,205 shares), MASTERS CAPITAL MANAGEMENT LLC (4,000,000 shares), VANGUARD GROUP INC (3,156,851 shares), StepStone Group LP (3,032,625 shares), CREDIT SUISSE AG/ (1,200,000 shares), INTERNATIONAL BIOTECHNOLOGY TRUST PLC (889,082 shares), MILLENNIUM MANAGEMENT LLC (868,654 shares), and BlackRock Inc. (684,133 shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.